Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 46


Alcohol Withdrawal Syndrome: Benzodiazepines and Beyond.

Sachdeva A, Choudhary M, Chandra M.

J Clin Diagn Res. 2015 Sep;9(9):VE01-VE07. doi: 10.7860/JCDR/2015/13407.6538. Epub 2015 Sep 1. Review.


Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics.

Blum K, Badgaiyan RD, Gold MS.

Cureus. 2015 Jul 27;7(7):e290. doi: 10.7759/cureus.290. eCollection 2015 Jul. Review. Erratum in: Cureus. 2015;7(9):c1. Retraction in: Blum K, Badgaiyan RD, Gold MS. Cureus. 2015;7(10):r1.


Alcohol liver disease: A review of current therapeutic approaches to achieve long-term abstinence.

García ML, Blasco-Algora S, Fernández-Rodríguez CM.

World J Gastroenterol. 2015 Jul 28;21(28):8516-26. doi: 10.3748/wjg.v21.i28.8516. Review.


[GABAB receptor as therapeutic target for drug addiction: from baclofen to positive allosteric modulators].

Agabio R, Colombo G.

Psychiatr Pol. 2015 Mar-Apr;49(2):215-23. doi: 10.12740/PP/33911. Review. Polish.


Recognition and management of withdrawal delirium (delirium tremens).

Schuckit MA.

N Engl J Med. 2014 Nov 27;371(22):2109-13. doi: 10.1056/NEJMra1407298. Review. No abstract available.


Alcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors.

Liang J, Olsen RW.

Acta Pharmacol Sin. 2014 Aug;35(8):981-93. doi: 10.1038/aps.2014.50. Review.


Clinical management of alcohol withdrawal: A systematic review.

Kattimani S, Bharadwaj B.

Ind Psychiatry J. 2013 Jul;22(2):100-8. doi: 10.4103/0972-6748.132914. Review.


Ethical and legal aspects of conducting clinical trials in alcohol withdrawal syndrome.

Reddy K V, R H.

J Clin Diagn Res. 2014 May;8(5):HE01-6. doi: 10.7860/JCDR/2014/6801.4323. Epub 2014 May 15. Review.


The predicted impact of reducing the nicotine content in cigarettes on alcohol use.

Dermody SS, Donny EC.

Nicotine Tob Res. 2014 Aug;16(8):1033-44. doi: 10.1093/ntr/ntu037. Epub 2014 Mar 19. Review.


Substance abuse and psychosis. The strange case of opioids.

Maremmani AG, Rovai L, Rugani F, Bacciardi S, Dell'Osso L, Maremmani I.

Eur Rev Med Pharmacol Sci. 2014;18(3):287-302. Review.


Outpatient management of alcohol withdrawal syndrome.

Muncie HL Jr, Yasinian Y, Oge' L.

Am Fam Physician. 2013 Nov 1;88(9):589-95. Review.


[Motivational processes in addiction: the role of craving, salience and attention].

Franken IH, Wiers RW.

Tijdschr Psychiatr. 2013;55(11):833-40. Review. Dutch.


Pharmacological strategies for detoxification.

Diaper AM, Law FD, Melichar JK.

Br J Clin Pharmacol. 2014 Feb;77(2):302-14. doi: 10.1111/bcp.12245. Review.


Glutamatergic targets for new alcohol medications.

Holmes A, Spanagel R, Krystal JH.

Psychopharmacology (Berl). 2013 Oct;229(3):539-54. doi: 10.1007/s00213-013-3226-2. Epub 2013 Sep 1. Review.


Medications for substance use disorders.

Douaihy AB, Kelly TM, Sullivan C.

Soc Work Public Health. 2013;28(3-4):264-78. doi: 10.1080/19371918.2013.759031. Review.


Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

Scavone JL, Sterling RC, Van Bockstaele EJ.

Neuroscience. 2013 Sep 17;248:637-54. doi: 10.1016/j.neuroscience.2013.04.034. Epub 2013 Apr 24. Review.


Psychiatric emergencies (part II): psychiatric disorders coexisting with organic diseases.

Testa A, Giannuzzi R, Sollazzo F, Petrongolo L, Bernardini L, Dain S.

Eur Rev Med Pharmacol Sci. 2013 Feb;17 Suppl 1:65-85. Review.


Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.

Zorrilla EP, Heilig M, de Wit H, Shaham Y.

Drug Alcohol Depend. 2013 Mar 1;128(3):175-86. doi: 10.1016/j.drugalcdep.2012.12.017. Epub 2013 Jan 5. Review.


The clinical pharmacology of acamprosate.

Kalk NJ, Lingford-Hughes AR.

Br J Clin Pharmacol. 2014 Feb;77(2):315-23. doi: 10.1111/bcp.12070. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk